Form 8-K - Current report:
SEC Accession No. 0001641172-25-011945
Filing Date
2025-05-22
Accepted
2025-05-21 18:27:19
Documents
12
Period of Report
2025-05-16
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 53192
  Complete submission text file 0001641172-25-011945.txt   228117

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE scnx-20250516.xsd EX-101.SCH 3042
3 XBRL LABEL FILE scnx-20250516_lab.xml EX-101.LAB 34916
4 XBRL PRESENTATION FILE scnx-20250516_pre.xml EX-101.PRE 24613
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3851
Mailing Address 2420 BRUNELLO TRACE LUTZ FL 33558
Business Address 2420 BRUNELLO TRACE LUTZ FL 33558 (800) 261 0281
Scienture Holdings, Inc. (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39199 | Film No.: 25974296
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)